APA

Fujiwara K., Yokosuka O., Komine F., Moriyama M., Kato N., Yoshida H., Tanaka N., Imazeki F., Shiratori Y., Arakawa Y. & Omata M. (20061204). Twenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1. : Liver international : official journal of the International Association for the Study of the Liver.

Chicago

Fujiwara Keiichi, Yokosuka Osamu, Komine Fumihiko, Moriyama Mitsuhiko, Kato Naoya, Yoshida Haruhiko, Tanaka Naohide, Imazeki Fumio, Shiratori Yasushi, Arakawa Yasuyuki and Omata Masao. 20061204. Twenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1. : Liver international : official journal of the International Association for the Study of the Liver.

Harvard

Fujiwara K., Yokosuka O., Komine F., Moriyama M., Kato N., Yoshida H., Tanaka N., Imazeki F., Shiratori Y., Arakawa Y. and Omata M. (20061204). Twenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1. : Liver international : official journal of the International Association for the Study of the Liver.

MLA

Fujiwara Keiichi, Yokosuka Osamu, Komine Fumihiko, Moriyama Mitsuhiko, Kato Naoya, Yoshida Haruhiko, Tanaka Naohide, Imazeki Fumio, Shiratori Yasushi, Arakawa Yasuyuki and Omata Masao. Twenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1. : Liver international : official journal of the International Association for the Study of the Liver. 20061204.